| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |